The longevity industry is no longer a niche—it’s a global economic force. In this episode, Alexia Brue speaks with Phil Newman, founder of Longevity.Technology, about how aging science is evolving from the lab into commercial markets. From diagnostics and AI to digital therapeutics and cellular reprogramming, Phil offers a macro view of where capital is flowing, which technologies are gaining traction, and why “healthspan” is the true opportunity of our time.

Inside this episode, learn:

• How longevity evolved from fringe science to a trillion-dollar opportunity
  
• Why healthspan—not just lifespan—will define the next decade
  
• Why longevity clinics are the new bridge between wellness and clinical care
  
• The 25 sub-domains tracked by Longevity.Technology (e.g. epigenetics, AI diagnostics)
  
• What investors, entrepreneurs, and policymakers need to understand about this fast-moving sector

Resources Mentioned:

Longevity.Technology
To learn more about the Global Wellness Institute please visit us at global wellness institute.org, connect with us on Instagram and subscribe to our YouTube channel.

Produced by: Emily Roberts and Ali Alquiza of Over Lunch

Hosted by: Alexia Brue, co-founder of Well+Good; founder of a new healthspan training studio, The Practice; member of the Global Wellness Institute Board of Advisors

Music provided by: Myndstream

Thank you to our sponsor, Fountain Life, for supporting the GWI Podcast. Head to FountainLife.com to learn more.

Subscribe, rate, & review wherever you listen to podcasts!